Works by Lewis, Karl


Results: 62
    1
    2

    A Case of Merkel Cell Carcinoma.

    Published in:
    Oncology (08909091), 2008, v. 22, n. 3, p. 322
    By:
    • Kudchadkar, Ragini;
    • Gonzalez, Rene;
    • Lewis, Karl;
    • Treichel, Krista;
    • Hammerman, Susan;
    • Robinson, William;
    • Fitzpatrick, James;
    • Gonzalez, Ricardo;
    • Kavanagh, Brian;
    • Rusthoven, Kyle
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 4, p. 609, doi. 10.1007/s00262-018-02295-4
    By:
    • D'Angelo, Sandra P.;
    • Hunger, Matthias;
    • Brohl, Andrew S.;
    • Nghiem, Paul;
    • Bhatia, Shailender;
    • Hamid, Omid;
    • Mehnert, Janice M.;
    • Terheyden, Patrick;
    • Shih, Kent C.;
    • Brownell, Isaac;
    • Lebbé, Céleste;
    • Lewis, Karl D.;
    • Linette, Gerald P.;
    • Milella, Michele;
    • Schlichting, Michael;
    • Hennessy, Meliessa H.;
    • Bharmal, Murtuza
    Publication type:
    Article
    10
    11
    12
    13

    POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae033
    By:
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Kohn, Amiee;
    • Tawbi, Hussein;
    • Weber, Jeffrey;
    • Flaherty, Keith;
    • McArthur, Grant A;
    • Ascierto, Paolo A;
    • Pfluger, Yanina;
    • Lewis, Karl;
    • Tsai, Katy K;
    • Hamid, Omid;
    • Prenen, Hans;
    • Fein, Luis;
    • Wang, Erjian;
    • Guenzel, Carolin;
    • Zhang, Fan;
    • Kleha, Joseph F;
    • Pietro, Alessandra di;
    • Davies, Michael A
    Publication type:
    Article
    14

    Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.

    Published in:
    2014
    By:
    • Carvajal, Richard D;
    • Sosman, Jeffrey A;
    • Quevedo, Jorge Fernando;
    • Milhem, Mohammed M;
    • Joshua, Anthony M;
    • Kudchadkar, Ragini R;
    • Linette, Gerald P;
    • Gajewski, Thomas F;
    • Lutzky, Jose;
    • Lawson, David H;
    • Lao, Christopher D;
    • Flynn, Patrick J;
    • Albertini, Mark R;
    • Sato, Takami;
    • Lewis, Karl;
    • Doyle, Austin;
    • Ancell, Kristin;
    • Panageas, Katherine S;
    • Bluth, Mark;
    • Hedvat, Cyrus
    Publication type:
    journal article
    15

    Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 311, n. 23, p. 2397, doi. 10.1001/jama.2014.6096
    By:
    • Carvajal, Richard D.;
    • Sosman, Jeffrey A.;
    • Quevedo, Jorge Fernando;
    • Milhem, Mohammed M.;
    • Joshua, Anthony M.;
    • Kudchadkar, Ragini R.;
    • Linette, Gerald P.;
    • Gajewski, Thomas F.;
    • Lutzky, Jose;
    • Lawson, David H.;
    • Lao, Christopher D.;
    • Flynn, Patrick J.;
    • Albertini, Mark R.;
    • Sato, Takami;
    • Lewis, Karl;
    • Doyle, Austin;
    • Ancell, Kristin;
    • Panageas, Katherine S.;
    • Bluth, Mark;
    • Hedvat, Cyrus
    Publication type:
    Article
    16
    17

    The importance of diversity, equity, and inclusion in orthopedic research.

    Published in:
    Journal of Orthopaedic Research, 2020, v. 38, n. 8, p. 1661, doi. 10.1002/jor.24685
    By:
    • Alliston, Tamara;
    • Foucher, Kharma C.;
    • Frederick, Brenda;
    • Hernandez, Christopher J.;
    • Iatridis, James C.;
    • Kozloff, Kenneth M.;
    • Lewis, Karl J.;
    • Liu, X. Sherry;
    • Mercer, Deana M.;
    • Ochia, Ruth;
    • Queen, Robin M.;
    • Rimnac, Clare M.;
    • Meulen, Marjolein C. H.;
    • Westendorf, Jennifer J.
    Publication type:
    Article
    18
    19
    20

    Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 2, p. 806, doi. 10.1245/s10434-021-10775-8
    By:
    • Torphy, Robert J.;
    • Friedman, Chloe;
    • Ho, Felix;
    • Leonard, Laura D.;
    • Thieu, Daniel;
    • Lewis, Karl D.;
    • Medina, Theresa M.;
    • Robinson, William A.;
    • Gonzalez, Rene C.;
    • Stewart, Camille L.;
    • Kounalakis, Nicole;
    • McCarter, Martin D.;
    • Gleisner, Ana
    Publication type:
    Article
    21
    22

    Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion.

    Published in:
    Journal of Translational Medicine, 2012, v. 10, n. 1, p. 236, doi. 10.1186/1479-5876-10-236
    By:
    • Ribas, Antoni;
    • Chesney, Jason A.;
    • Gordon, Michael S.;
    • Abernethy, Amy P.;
    • Logan, Theodore F.;
    • Lawson, David H.;
    • Chmielowksi, Bartosz;
    • Glaspy, John A.;
    • Lewis, Karl;
    • Bo Huang;
    • Erjian Wang;
    • Poe-Hirr Hsyu;
    • Gomez-Navarro, Jesus;
    • Gerhardt, Diana;
    • Marshall, Margaret A.;
    • Gonzalez, Rene
    Publication type:
    Article
    23
    24
    25

    Gabapentin Disrupts Binding of Perlecan to the α 2 δ 1 Voltage Sensitive Calcium Channel Subunit and Impairs Skeletal Mechanosensation.

    Published in:
    Biomolecules (2218-273X), 2022, v. 12, n. 12, p. 1857, doi. 10.3390/biom12121857
    By:
    • Reyes Fernandez, Perla C.;
    • Wright, Christian S.;
    • Masterson, Adrianna N.;
    • Yi, Xin;
    • Tellman, Tristen V.;
    • Bonteanu, Andrei;
    • Rust, Katie;
    • Noonan, Megan L.;
    • White, Kenneth E.;
    • Lewis, Karl J.;
    • Sankar, Uma;
    • Hum, Julia M.;
    • Bix, Gregory;
    • Wu, Danielle;
    • Robling, Alexander G.;
    • Sardar, Rajesh;
    • Farach-Carson, Mary C.;
    • Thompson, William R.
    Publication type:
    Article
    26

    IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.

    Published in:
    Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01223
    By:
    • Tobin, Richard P.;
    • Jordan, Kimberly R.;
    • Kapoor, Puja;
    • Spongberg, Eric;
    • Davis, Dana;
    • Vorwald, Victoria M.;
    • Couts, Kasey L.;
    • Gao, Dexiang;
    • Smith, Derek E.;
    • Borgers, Jessica S. W.;
    • Robinson, Steven;
    • Amato, Carol;
    • Gonzalez, Rene;
    • Lewis, Karl D.;
    • Robinson, William A.;
    • Borges, Virginia F.;
    • McCarter, Martin D.
    Publication type:
    Article
    27

    Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-18988-3
    By:
    • Newell, Felicity;
    • Wilmott, James S.;
    • Johansson, Peter A.;
    • Nones, Katia;
    • Addala, Venkateswar;
    • Mukhopadhyay, Pamela;
    • Broit, Natasa;
    • Amato, Carol M.;
    • Van Gulick, Robert;
    • Kazakoff, Stephen H.;
    • Patch, Ann-Marie;
    • Koufariotis, Lambros T.;
    • Lakis, Vanessa;
    • Leonard, Conrad;
    • Wood, Scott;
    • Holmes, Oliver;
    • Xu, Qinying;
    • Lewis, Karl;
    • Medina, Theresa;
    • Gonzalez, Rene
    Publication type:
    Article
    28

    A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.

    Published in:
    Cancers, 2020, v. 12, n. 8, p. 2270, doi. 10.3390/cancers12082270
    By:
    • Hasanov, Merve;
    • Rioth, Matthew J.;
    • Kendra, Kari;
    • Hernandez-Aya, Leonel;
    • Joseph, Richard W.;
    • Williamson, Stephen;
    • Chandra, Sunandana;
    • Shirai, Keisuke;
    • Turner, Christopher D.;
    • Lewis, Karl;
    • Crowley, Elizabeth;
    • Moscow, Jeffrey;
    • Carter, Brett;
    • Patel, Sapna
    Publication type:
    Article
    29

    Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.

    Published in:
    Cancers, 2020, v. 12, n. 7, p. 1943, doi. 10.3390/cancers12071943
    By:
    • Amato, Carol M.;
    • Hintzsche, Jennifer D.;
    • Wells, Keith;
    • Applegate, Allison;
    • Gorden, Nicholas T.;
    • Vorwald, Victoria M.;
    • Tobin, Richard P.;
    • Nassar, Kelsey;
    • Shellman, Yiqun G.;
    • Kim, Jihye;
    • Medina, Theresa M.;
    • Rioth, Matthew;
    • Lewis, Karl D.;
    • McCarter, Martin D.;
    • Gonzalez, Rene;
    • Tan, Aik-Choon;
    • Robinson, William A.
    Publication type:
    Article
    30
    31
    32

    Deletion of the auxiliary α<sub>2</sub>δ<sub>1</sub> voltage sensitive calcium channel subunit in osteocytes and late-stage osteoblasts impairs femur strength and load-induced bone formation in male mice.

    Published in:
    Journal of Bone & Mineral Research, 2024, v. 39, n. 3, p. 298, doi. 10.1093/jbmr/zjae010
    By:
    • Wright, Christian S;
    • Lewis, Karl J;
    • Semon, Katelyn;
    • Yi, Xin;
    • Fernandez, Perla C Reyes;
    • Rust, Katie;
    • Prideaux, Matthew;
    • Schneider, Artur;
    • Pederson, Molly;
    • Deosthale, Padmini;
    • Plotkin, Lilian I;
    • Hum, Julia M;
    • Sankar, Uma;
    • Farach-Carson, Mary C;
    • Robling, Alexander G;
    • Thompson, William R
    Publication type:
    Article
    33
    34
    35

    A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 10, p. 1784, doi. 10.1002/cncr.35200
    By:
    • Algazi, Alain P.;
    • Moon, James;
    • Lao, Christopher D.;
    • Chmielowski, Bartosz;
    • Kendra, Kari L.;
    • Lewis, Karl D.;
    • Gonzalez, Rene;
    • Kim, Kevin;
    • Godwin, John E.;
    • Curti, Brendan D.;
    • Latkovic-Taber, Michaella;
    • Lomeli, Shirley H.;
    • Gufford, Brandon T.;
    • Scumpia, Philip O.;
    • Lo, Roger S.;
    • Othus, Megan;
    • Ribas, Antoni
    Publication type:
    Article
    36
    37
    38

    Musculoskeletal mechanobiology.

    Published in:
    Connective Tissue Research, 2022, v. 63, n. 1, p. 1, doi. 10.1080/03008207.2021.2005172
    By:
    • Lewis, Karl J.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00214-y
    By:
    • Mansfield, Aaron S.;
    • Hong, David S.;
    • Hann, Christine L.;
    • Farago, Anna F.;
    • Beltran, Himisha;
    • Waqar, Saiama N.;
    • Hendifar, Andrew E.;
    • Anthony, Lowell B.;
    • Taylor, Matthew H.;
    • Bryce, Alan H.;
    • Tagawa, Scott T.;
    • Lewis, Karl;
    • Niu, Jiaxin;
    • Chung, Christine H.;
    • Cleary, James M.;
    • Rossi, Michael;
    • Ludwig, Carrianne;
    • Valenzuela, Ricardo;
    • Luo, Yan;
    • Aggarwal, Rahul
    Publication type:
    Article
    45
    46
    47
    48
    49
    50